Year archive

PharmaSGP Holding SE — 2025 filings

All 31 regulatory filings released by PharmaSGP Holding SE (PSG) in 2025, sourced directly from the official regulator.

31 Filings

2025 Period

2025 filings (31)

Filing	Released	Lang
FUTRUE increases adequate cash compensation under the squeeze-out Delisting Announcement	2025-10-28	English
PharmaSGP convenes extraordinary general meeting to resolve on Squeeze-out AGM Information	2025-09-22	English
Report Publication Announcement 2025 Report Publication Announcement	2025-09-19	English
PharmaSGP publishes preliminary half-year figures for 2025 Earnings Release H1 2025	2025-09-11	English
PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 1,315 additional shares of PharmaSGP Holding SE in delisting tender offer between the reporting date of the announcement published on August 11, Director's Dealing	2025-08-14	English
PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 39,678 additional shares of PharmaSGP Holding SE in the delisting tender offer between the reporting date of the announcement published on Augus Director's Dealing	2025-08-11	English
PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 873 additional shares of PharmaSGP Holding SE in the delisting tender offer between the reporting date of the announcement published on August 7 Director's Dealing	2025-08-08	English
PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 1,505 additional shares of PharmaSGP Holding SE in the delisting tender offer between the reporting date of the announcement published on August Director's Dealing	2025-08-07	English
PharmaSGP Holding SE: Delisting of PharmaSGP shares from Frankfurt Stock Exchange effective upon the expiry of August 11, 2025 Delisting Announcement	2025-08-06	English
PharmaSGP Holding SE: Michael Rudolf, Tender of 4,169 shares within the public delisting tender offer (cash offer) of FUTRUE GmbH Director's Dealing	2025-08-05	English
PharmaSGP Holding SE: Dr. Clemens Fischer, Tender of a total of 6,062 additional shares of PharmaSGP Holding SE in the delisting tender offer between the reporting date of the announcement published Director's Dealing	2025-08-04	English
PharmaSGP Holding SE publishes joint reasoned statement of the Management Board and Supervisory Board on the public delisting tender offer by FUTRUE GmbH Delisting Announcement	2025-07-28	English
PharmaSGP Holding SE: FUTRUE GmbH, Tender of an additional total of 4,491 shares of PharmaSGP Holding SE into the delisting tender offer between the reporting date of the announcement published on 21 Director's Dealing	2025-07-28	English
PharmaSGP Holding SE: FUTRUE GmbH, buy Director's Dealing	2025-07-24	English
FUTRUE GmbH submits request to implement squeeze-out of minority shareholders of PharmaSGP Holding SE Delisting Announcement	2025-07-24	English
Declaration of Voting Results & Voting Rights Announcements 2025 Declaration of Voting Results & Voting Rights Announcements	2025-07-23	English
PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 540 shares in PharmaSGP Holding SE in a delisting tender offer by the reporting date of the announcement published on July 21, 2025, pursuant to Director's Dealing	2025-07-23	English
PharmaSGP Holding SE: Acceptance period for FUTRUE GmbHs public delisting tender offer underway Delisting Announcement	2025-07-18	English
PharmaSGP Holding SE adjusts its revenues forecast for the full year 2025 Earnings Release FY 2025	2025-07-11	English
PharmaSGP Holding SE holds 2025 Annual General Meeting AGM Information	2025-06-26	English
PharmaSGP SE plans to redeem own shares conditions for squeeze-out under conversion law are met Transaction in Own Shares	2025-06-18	English
PharmaSGP Holding SE: FUTRUE GmbH, Interest-sustaining purchase order for up to 720,000 shares of PharmaSGP Holding SE in the period from June 10, 2025 at a maximum purchase price of EUR 28.00 per sha Director's Dealing	2025-06-11	English
PharmaSGP Holding SE: Conclusion of a delisting agreement and announcement of a delisting tender offer by FUTRUE GmbH Delisting Announcement	2025-06-10	English
Q1 statement / Q1 financial report 2025 Interim / Quarterly Report Q1 2025	2025-05-28	English
PharmaSGP Holding SE: FUTRUE GmbH, buy Director's Dealing	2025-05-19	English
PharmaSGP continues its growth course in 2025 Earnings Release Q1 2025	2025-05-16	English
PharmaSGP Holding SE: Bekanntmachung der Einberufung zur Hauptversammlung am 25.06.2025 in Grafelfing mit dem Ziel der europaweiten Verbreitung gema 121 AktG AGM Information	2025-05-14	German
Declaration of Voting Results & Voting Rights Announcements 2025 Declaration of Voting Results & Voting Rights Announcements	2025-05-09	English
Annual financial report 2024 Annual Report FY 2024	2025-04-30	English
Report Publication Announcement 2025 Report Publication Announcement	2025-04-23	English
PharmaSGP with significant increase in revenues and EBITDA in 2024 Earnings Release FY 2024	2025-04-15	English